Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page adds a Revision: v3.3.3 label and removes the HHS Vulnerability Disclosure and Revision: v3.3.2 links from the footer. These are administrative site updates with no impact on study content or user interaction.
    Difference
    0.1%
    Check dated 2025-12-23T08:10:51.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.3.1 to v3.3.2 on the page footer, with no observed changes to study details, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:23:20.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Publications section now notes that entries are automatically filled from PubMed and may not all relate to the study. The page revision has been updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:37:28.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The government funding/operating status notice was removed from the page; other study details, eligibility criteria, and trial information appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:48:06.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The update shows minor UI adjustments and a refreshed last-updated date, with no changes to core study information such as eligibility, interventions, outcomes, or participating sites. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:12:13.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Update includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.
    Difference
    3%
    Check dated 2025-10-05T09:14:50.000Z thumbnail image

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.